This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jun 1;28(6):1406.

doi: 10.1093/annonc/mdx077.

Addressing the quality of the ESMO-MCBS

J C Del Paggio¹

Affiliations

PMID: 28327902
DOI: 10.1093/annonc/mdx077

Free article

Comment

Addressing the quality of the ESMO-MCBS

J C Del Paggio. Ann Oncol. 2017.

Free article

. 2017 Jun 1;28(6):1406.

doi: 10.1093/annonc/mdx077.

Author

J C Del Paggio¹

Affiliation

¹ Department of Medicine, University of Toronto, Toronto, Canada.

PMID: 28327902
DOI: 10.1093/annonc/mdx077

No abstract available

PubMed Disclaimer

Comment in

Reply to the letter to the editor 'Addressing the quality of the ESMO-MCBS' by Del Paggio.
Cherny NI, Dafni U, Bogaerts J, Pentheroudakis G, Tabernero J, Zielinski C, Piccart M, de Vries EGE. Cherny NI, et al. Ann Oncol. 2017 Aug 1;28(8):2031-2032. doi: 10.1093/annonc/mdx200. Ann Oncol. 2017. PMID: 28430861 No abstract available.

Comment on

A standardised, generic, validated approach to stratify the magnitude of clinical benefit that can be anticipated from anti-cancer therapies: the European Society for Medical Oncology Magnitude of Clinical Benefit Scale (ESMO-MCBS).
Cherny NI, Sullivan R, Dafni U, Kerst JM, Sobrero A, Zielinski C, de Vries EG, Piccart MJ. Cherny NI, et al. Ann Oncol. 2015 Aug;26(8):1547-73. doi: 10.1093/annonc/mdv249. Epub 2015 May 30. Ann Oncol. 2015. PMID: 26026162

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations